[A randomized phase II clinical trial of tailored CPT-11 + TS-1 vs TS-1 in patients with advanced or recurrent gastric carcinoma as the first-line chemotherapy (JFMC31-0301)].

Yutaka Takahashi(Kanazawa University), Shigetoyo Saji(Gifu University), Masaki Kitajima(Keio University Hospital), Tetsuo Takeuchi(Okayama University Hospital), Masayoshi Mai, Tetsuro Kubota(Keio University), Tetsuya Toge(Hiroshima University), Jyunichi Sakamoto
PubMed
November 1, 2004
Cited by 0

Related Papers

Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation1
|Transplantation|2002|151
Liver Regeneration in Donors and Adult Recipients After Living Donor Liver Transplantation
|Liver Transplantation|2008|136
The role of Fas ligand and transforming growth factor β in tumor progression
|Cancer|2004|135
The Role of Tumor Necrosis Factor-α and Interleukin-1β in Ischemia-Reperfusion Injury of the Rat Small Intestine
|Journal of Surgical Research|2001|123